MDT - Medtronic plc


95.6
-1.110   -1.161%

Share volume: 7,084,009
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%

$96.71
-1.11
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 41%
Dept financing 19%
Liquidity 25%
Performance 61%
Company vs Stock growth
vs
Performance
5 Days
-2.55%
1 Month
-7.14%
3 Months
-5.68%
6 Months
2.91%
1 Year
1.64%
2 Year
13.00%
Key data
Stock price
$95.60
P/E Ratio 
28.04
DAY RANGE
$95.42 - $96.90
EPS 
$3.59
52 WEEK RANGE
$79.55 - $106.33
52 WEEK CHANGE
$2.65
MARKET CAP 
129.330 B
YIELD 
2.81%
SHARES OUTSTANDING 
1.284 B
DIVIDEND
$0.71
EX-DIVIDEND DATE
12-26-2025
NEXT EARNINGS DATE
08-19-2025
BETA 
0.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$7,101,571
AVERAGE 30 VOLUME 
$9,021,166
Company detail
CEO: Geoffrey S. Martha
Region: US
Website: medtronic.com
Employees: 95,000
IPO year: 1981
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies. It operates through four segments: Cardiovascular, Neuroscience, Medical Surgical Portfolio, and Diabetes Operating Unit. The Neuroscience Portfolio segment offers products for spinal surgeons, neurosurgeons, neurologists; neurologists, pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists.

Recent news